On Friday, AbCellera Biologics Inc (NASDAQ: ABCL) was -1.15% drop from the session before settling in for the closing price of $2.60. A 52-week range
AbCellera Biologics Inc (NASDAQ: ABCL) established initial surge of 0.40% at $2.53, as the Stock market unbolted on Wednesday, before settling in for the price
AbCellera Biologics Inc (NASDAQ: ABCL) kicked off on Thursday, up 1.26% from the previous trading day, before settling in for the closing price of $2.39.
AbCellera Biologics Inc (NASDAQ: ABCL) started the day on Wednesday, with a price decrease of -1.65% at $2.39, before settling in for the price of
On Friday, AbCellera Biologics Inc (NASDAQ: ABCL) was 15.94% up from the session before settling in for the closing price of $2.07. A 52-week range
AbCellera Biologics Inc (NASDAQ: ABCL) kicked off on Tuesday, down -5.85% from the previous trading day, before settling in for the closing price of $2.05.
On Monday, AbCellera Biologics Inc (NASDAQ: ABCL) opened lower -3.46% from the last session, before settling in for the closing price of $2.31. Price fluctuations
As on Thursday, AbCellera Biologics Inc (NASDAQ: ABCL) started slowly as it slid -2.48% to $2.36, before settling in for the price of $2.42 at
kicked off on Monday, with AbCellera Biologics Inc (NASDAQ: ABCL) stock price up 6.15% from the previous day of trading, before settling in for the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
